Jessica Lam, MD
Colon & Rectal Surgery · Atlanta, GANPI 1114451382
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (53.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 68.1% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2023 at $5,042 and has fallen 95.0% since, to $252 in 2025.
Across 44 payments — averaging $174.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$5K
- Medtronic$1K
- THD America, Inc.$864
- Medical Device Business Services, Inc.$137
- Takeda Pharmaceuticals U.S.A., Inc.$80
- Baxter Healthcare$29
- plus $146 from 6 others
What the payments were for
- Travel & lodging$2,15328%
- Food & beverage$1,38418%
- Education$4,13754%
- Gifts$90%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 11 | $5,231 |
| Medtronic | 18 | $1,195 |
| THD America, Inc. | 3 | $864 |
| Medical Device Business Services, Inc. | 1 | $137 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $80 |
| Baxter Healthcare | 2 | $29 |
| Johnson & Johnson | 1 | $28 |
| Vertex | 1 | $28 |
| Braintree Laboratories, Inc. | 1 | $26 |
| Innovation Technologies Inc | 1 | $26 |
| Solventum Corporation | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$4,000
- Da Vinci Surgical System$992
- INTERSTIM$539
How this compares
$7,682 in reported general payments places this provider in the 60th percentile of 66 colon & rectal surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 13 | $641 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 25 | $133 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $98 |
| Metronidazole | 11 | $35 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Atlanta
- Patrick SullivanAtlanta$41K
- Sander BinderowAtlanta$20K
- Daniel Sarmiento GarzonAtlanta$14K
- Joseph MarenoAtlanta$13K
- Evan FeldmanAtlanta$7K
- Cici ZhangAtlanta$5K
- Ellen CaparosaAtlanta$5K
- Monica HumAtlanta$5K
- Gie YuAtlanta$3K
- Stephanie PappasAtlanta$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.